home / stock / apls / apls short
Short Information | Apellis Pharmaceuticals Inc. (NASDAQ:APLS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 6,179,749 |
Total Actual Volume | 36,691,834 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 308,987 |
Average Short Percentage | 16.54% |
Is there a APLS Short Squeeze or Breakout about to happen?
See the APLS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-07-2024 | $45.1 | $43.9 | $47.6 | $41.7525 | 4,517,931 | 1,022,228 | 22.63% |
05-06-2024 | $47.32 | $48.81 | $49.06 | $47.175 | 1,846,996 | 463,941 | 25.12% |
05-03-2024 | $48.46 | $47.46 | $48.76 | $47.22 | 1,106,943 | 161,784 | 14.62% |
05-02-2024 | $46.62 | $47.49 | $47.74 | $46.1 | 1,020,629 | 120,435 | 11.8% |
05-01-2024 | $44.75 | $46.05 | $47.23 | $44.49 | 2,333,759 | 403,194 | 17.28% |
04-30-2024 | $46.6 | $44.19 | $46.8499 | $38.2188 | 6,668,374 | 996,356 | 14.94% |
04-29-2024 | $48.98 | $47.84 | $49.38 | $47.56 | 1,400,648 | 133,045 | 9.5% |
04-26-2024 | $50 | $49.86 | $50.98 | $48.85 | 1,215,021 | 216,334 | 17.8% |
04-25-2024 | $49.27 | $47.93 | $49.31 | $47.02 | 1,122,466 | 218,796 | 19.49% |
04-24-2024 | $48.84 | $49.93 | $50.405 | $48.6241 | 1,224,198 | 160,416 | 13.1% |
04-23-2024 | $48.18 | $48.72 | $50 | $47.97 | 1,184,392 | 278,435 | 23.51% |
04-22-2024 | $48.08 | $47.64 | $48.42 | $46.63 | 784,535 | 90,449 | 11.53% |
04-19-2024 | $47.52 | $47.53 | $48.19 | $46.53 | 1,179,340 | 274,433 | 23.27% |
04-18-2024 | $47.91 | $47.51 | $48.83 | $46.4 | 1,946,309 | 352,083 | 18.09% |
04-17-2024 | $51.67 | $48.03 | $52.44 | $47.96 | 1,678,817 | 368,566 | 21.95% |
04-16-2024 | $51.4 | $51.82 | $53.06 | $50.7 | 1,007,786 | 107,344 | 10.65% |
04-15-2024 | $51.76 | $51.5 | $53.04 | $50.28 | 2,616,448 | 185,448 | 7.09% |
04-12-2024 | $55.13 | $51.79 | $55.5999 | $50.07 | 2,002,863 | 350,716 | 17.51% |
04-11-2024 | $57.15 | $55.73 | $57.85 | $55.22 | 1,053,934 | 135,281 | 12.84% |
04-10-2024 | $53.71 | $56.84 | $57.03 | $53.71 | 780,445 | 140,465 | 18% |
News, Short Squeeze, Breakout and More Instantly...
Apellis Pharmaceuticals Inc. Company Name:
APLS Stock Symbol:
NASDAQ Market:
Generated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales $137.5 million for SYFOVRE® (pegcetacoplan injection) $25.6 million for EMPAVELI® (pegcetacoplan) Anticipates CHMP opinion for pegcetacoplan in GA no later than J...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...
WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) today announced that the company will host a fires...